Clinical Trial Update: A Study of LY2784544 in Participants With Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY2784544 in participants with myeloproliferative neoplasms; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Drugs mentioned

• LY2784544

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Hematologic | Phase 2 | Status: ACTIVE_NOT_RECRUITING